Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)

  • Business News
  • March 29, 2026, 07:11 UTC
  • 5
  • 1 comments

Max (in parenthesis) published the results of a public tender for the issuance of commercial papers 6

Market reaction Comment Full text

DUNIEC BROS. LTD. (DUNI)

  • Business News
  • March 29, 2026, 06:58 UTC
  • 4
  • 1 comments

Conference call to review the financial statements for 2025 on 30.3.26 at 15:00

Market reaction Comment Full text

CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)

  • Business News
  • March 29, 2026, 06:40 UTC
  • 5
  • 1 comments

The District Court rejected a motion for a class action against subsidiaries regarding the sale of Alrov

Market reaction Comment Full text

SUMMIT REAL ESTATE HOLDINGS LTD (SMT)

  • Business News
  • March 29, 2026, 06:38 UTC
  • 5
  • 1 comments

Conference call to review the financial statements for 2025 on March 31, 2026 at 14:00

Market reaction Comment Full text

BANK HAPOALIM B.M. (POLI)

  • Business News
  • March 29, 2026, 06:35 UTC
  • 5
  • 1 comments

Dormant shares

Market reaction Comment Full text

MIVTACH SHAMIR HOLDINGS LTD. (MISH)

  • Business News
  • March 29, 2026, 05:46 UTC
  • 5
  • 1 comments

Events and transactions

Market reaction Comment Full text

Novartis AG (NVS)

  • Business News
  • March 29, 2026, 05:15 UTC
  • 6
  • 1 comments

Novartis IgAN data in New England Journal of Medicine showFabhalta® slowed kidney function decline by 49.3%

Market reaction Comment Full text

Y.H.DIMRI CONTRUCTION & DEVELOPMENT LTD (DIMRI)

  • Business News
  • March 29, 2026, 04:26 UTC
  • 5
  • 1 comments

Change in holdings of interested parties/officers

Market reaction Comment Full text

SUPER MICRO COMPUTER, INC. (SMCI)

  • Business News
  • March 29, 2026, 04:23 UTC
  • 5
  • 1 comments

SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

IMMUNITYBIO, INC. (IBRX)

  • Business News
  • March 29, 2026, 04:13 UTC
  • 5
  • 1 comments

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • Previous
  • 573
  • 574
  • 575
  • 576
  • 577
  • Next

Search

News categories

  • Technical Exchange News(11754)
  • Event(4259)
  • SEC News(235066)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143210)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin